Alembic Pharmaceuticals Limited (BOM:533573)
India flag India · Delayed Price · Currency is INR
935.05
-15.15 (-1.59%)
At close: Aug 8, 2025

Splunk Statistics

Total Valuation

BOM:533573 has a market cap or net worth of INR 184.02 billion. The enterprise value is 195.75 billion.

Market Cap184.02B
Enterprise Value 195.75B

Important Dates

The last earnings date was Monday, August 4, 2025.

Earnings Date Aug 4, 2025
Ex-Dividend Date Jul 29, 2025

Share Statistics

Current Share Class 196.56M
Shares Outstanding n/a
Shares Change (YoY) -0.10%
Shares Change (QoQ) +0.03%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 57.33M

Valuation Ratios

The trailing PE ratio is 30.51 and the forward PE ratio is 24.43.

PE Ratio 30.51
Forward PE 24.43
PS Ratio 2.70
PB Ratio 3.55
P/TBV Ratio 3.55
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 32.46
EV / Sales 2.87
EV / EBITDA 18.65
EV / EBIT 25.43
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.24
Debt / EBITDA 1.20
Debt / FCF n/a
Interest Coverage 8.64

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 8.17%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 4.12M
Profits Per Employee 363,943
Employee Count16,571
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, BOM:533573 has paid 1.39 billion in taxes.

Income Tax 1.39B
Effective Tax Rate 18.80%

Stock Price Statistics

The stock price has decreased by -23.35% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -23.35%
50-Day Moving Average 987.42
200-Day Moving Average 965.62
Relative Strength Index (RSI) 34.58
Average Volume (20 Days) 7,601

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BOM:533573 had revenue of INR 68.21 billion and earned 6.03 billion in profits. Earnings per share was 30.69.

Revenue68.21B
Gross Profit 49.27B
Operating Income 7.70B
Pretax Income 7.40B
Net Income 6.03B
EBITDA 10.30B
EBIT 7.70B
Earnings Per Share (EPS) 30.69
Full Income Statement

Balance Sheet

The company has 834.80 million in cash and 12.58 billion in debt, giving a net cash position of -11.74 billion.

Cash & Cash Equivalents 834.80M
Total Debt 12.58B
Net Cash -11.74B
Net Cash Per Share n/a
Equity (Book Value) 51.90B
Book Value Per Share 264.09
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 72.23%, with operating and profit margins of 11.28% and 8.84%.

Gross Margin 72.23%
Operating Margin 11.28%
Pretax Margin 10.85%
Profit Margin 8.84%
EBITDA Margin 15.11%
EBIT Margin 11.28%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 1.16%.

Dividend Per Share 11.00
Dividend Yield 1.16%
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield 0.10%
Shareholder Yield 1.27%
Earnings Yield 3.28%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2